Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07493720 · ClinicalTrials.gov registry record
Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood
A clinical trial, sponsored by University of Nebraska.
- Not yet
- Registry status
- 40
- Enrollment target
NCT07493720 is a clinical trial that has not yet begun recruiting, run by University of Nebraska. The registered enrollment target is 40 participants.
The verdict
NCT07493720 has not yet begun recruiting, sponsored by University of Nebraska.
- NOT YET RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
The objective of his study is to quantitatively evaluate a patient's pregnancy status using their beta-hCG levels when using venipuncture blood vs peripheral blood.
Interventions
- DIAGNOSTIC_TEST Beta-hCG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07493720
The ClinicalTrials.gov registry entry for NCT07493720 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Beta-hCG is the first listed.
NCT07493720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07493720 about?
NCT07493720 is a clinical study titled "Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood". The objective of his study is to quantitatively evaluate a patient's pregnancy status using their beta-hCG levels when using venipuncture blood vs peripheral blood.
What is the current status of trial NCT07493720?
This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2026-07. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07493720?
The interventions under investigation include: Beta-hCG (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07493720?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.